[Recurrent amylase-producing multiple myeloma responding to pomalidomide and carfilzomib-containing therapies].

Aota, Yasuo; Gotoh, Akihiko; Okuda, Yuko; Honda, Tadahiro; Watanabe, Naoki; Ando, Jun; Komatsu, Norio

Aota, Yasuo; Gotoh, Akihiko; Okuda, Yuko; Honda, Tadahiro; Watanabe, Naoki; Ando, Jun; Komatsu, Norio.

Afiliación

Aota Y; Department of Internal Medicine, Kohsei Chuo General Hospital.
Gotoh A; Department of Hematology, Juntendo University School of Medicine.
Okuda Y; Department of Internal Medicine, Kohsei Chuo General Hospital.
Honda T; Department of Hematology, Juntendo University School of Medicine.
Watanabe N; Department of Internal Medicine, Kohsei Chuo General Hospital.
Ando J; Department of Internal Medicine, Kohsei Chuo General Hospital.
Komatsu N; Department of Hematology, Juntendo University School of Medicine.

Rinsho Ketsueki ; 59(7): 865-871, 2018.

Article en Ja | MEDLINE | ID: mdl-30078795

Asunto(s)

Mieloma Múltiple/tratamiento farmacológico; Oligopéptidos/uso terapéutico; Talidomida/análogos & derivados; Anciano; Amilasas; Protocolos de Quimioterapia Combinada Antineoplásica; Bortezomib/uso terapéutico; Dexametasona/uso terapéutico; Femenino; Humanos; Mieloma Múltiple/enzimología; Talidomida/uso terapéutico

Palabras clave

Carfilzomib; Multiple myeloma; Pomalidomide; Salivary-type amylase

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Oligopéptidos / Talidomida / Mieloma Múltiple Límite: Aged / Female / Humans Idioma: Ja Revista: Rinsho Ketsueki Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google